Webinar: FOXG1 Fintepla Clinical Trail скачать в хорошем качестве

Webinar: FOXG1 Fintepla Clinical Trail

Enrollment is open for the anti-epilepsy medication Fintepla for patients with FOXG1 syndrome. When we learned about the success of the new epilepsy medication, Fintepla, in other rare disease epilepsy clinical trials, we began working with NYU and Zogenix (Now UCB) to launch a trial for FOXG1 patients. We worked to make this an open trial so that our FOXG1 patients do not have to travel to NYC to participate. In this webinar, the Director of NYU's Comprehensive Epilepsy Center Dr. Orrin Devinsky talks about the success in other epilepsies, he explains how the trial works, and answer parents questions. This trial marks a major milestone for FOXG1 syndrome. This will be just the first of many clinical trials designed to help all of our children live easier, healthier lives. Please reach out directly to NYU directly to enroll. Contact information is in this webinar. Help cure FOXG1 syndrome: https://foxg1research.org/donate